Evidence map›Paper›PMID 26015481›Full record

ArticleInfection and immunity2015

Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.

Antonina Torre, Marta Bacconi, Chiara Sammicheli, Bruno Galletti, Donatello Laera, Maria Rita Fontana, Guido Grandi, Ennio De Gregorio, Fabio Bagnoli, Sandra Nuti and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Overcoming Immune Evasion inACS infectious diseases · 2025
    Review
  3. A promisingClinical and experimental vaccine research · 2025
    Review
  4. Article
  5. Review
  6. Performance of a Four-AntigenMicroorganisms · 2021
    Article
  7. Frontiers in microbiology · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2018
    Article
  12. The open microbiology journal · 2018
    Article
  13. Article
  14. Epic Immune Battles of History: Neutrophils vs.Frontiers in cellular and infection microbiology · 2017
    Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Antonina TorreNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Marta BacconiNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Chiara SammicheliNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Bruno GallettiNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Donatello LaeraNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Maria Rita FontanaNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Guido GrandiNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Ennio De GregorioNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Fabio BagnoliNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Sandra NutiNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Sylvie BertholetNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy.
Giuliano BensiNovartis Vaccines and Diagnostics, s.r.l., a GSK Company, Siena, Italy giuliano.x.bensi@gsk.com.
Novartis (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus aureus is a human bacterial pathogen causing a variety of diseases. The occurrence of multidrug-resistant strains of Staphylococcus aureus underlines the need for a vaccine. Defining immune correlates of protection may support the design of an effective vaccine. We used a murine Staphylococcus aureus infection model, in which bacteria were inoculated in an air pouch generated on the back of the animal. Analysis of the air-pouch content in mice immunized or not with an adjuvanted multiantigen vaccine formulation, four-component S. aureus vaccine (4C-Staph), prior to infection allowed us to measure bacteria, cytokines, and 4C-Staph-specific antibodies and to analyze host immune cells recruited to the infection site. Immunization with 4C-Staph resulted in accumulation of antigen-specific antibodies in the pouch and mitigated the infection. Neutrophils were the most abundant cells in the pouch, and they showed the upregulation of Fcγ receptor (FcγR) following immunization with 4C-Staph. Reduction of the infection was also obtained in mice immunized with 4C-Staph and depleted of neutrophils; these mice showed an increase in monocytes and macrophages. Upregulation of the FcγR and the presence of antigen-specific antibodies induced by immunization with 4C-Staph may contribute to increase bacterial opsonophagocytosis. Protection in neutropenic mice indicated that an effective vaccine could activate alternative protection mechanisms compensating for neutropenia, a condition often occurring in S. aureus-infected patients.

Indexed as

AnimalsAntibodies, BacterialDisease Models, AnimalFemaleHumansImmunizationMiceMice, Inbred C57BLMonocytesNeutropeniaNeutrophilsReceptors, IgGStaphylococcal InfectionsStaphylococcal VaccinesStaphylococcus aureusAntibodies, BacterialReceptors, IgGStaphylococcal Vaccines

Identifiers

PMID26015481
PMCPMC4496606
OpenAlexW1813098396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.